Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4945 total record number 317 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 20 out of 34
336 citations found

Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin

Trescos, Y;Tessier, E;Rougeaux, C;Goossens, PL;Tournier, JN;

Product: Anthrax Edema Factor (EF), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Immunization screening:

    The threshold dose of PA for rabbits was chosen by injecting rabbits intramuscularly (i.m.) on days 0 and 14 with either 10 g, 1 g, 0.1 g, 0.01 g, or 0 g of PA (List Biological Laboratories, Campbell, Calif.) diluted in PBS in a volume of 0.5 ml, each adsorbed to 1 mg of aluminum per ml … The primary and secondary antibody response profiles were examined by injecting rabbits i.m. with 50 g of PA/Alhydrogel on days 0 and 21 and collecting blood periodically to test serum for the presence of antibodies to PA and TNA titers in the serum.

    2.3. Protection against aerosol exposure

    Rabbits were injected i.m. with 0.1 g of PA/Alhydrogel and boosted with 0.1 g of PA/Alhydrogel 4 days (day 86), 8 days (day 82), or 12 days (day 78) before aerosol exposure on day 90 following the primary immunization. …

Novel Furin Inhibitors with Potent Anti-infectious Activity

Hardes, K;Becker, GL;Lu, Y;Dahms, SO;Khler, S;Beyer, W;Sandvig, K;Yamamoto, H;Lindberg, I;Walz, L;von Messling, V;Than, ME;Garten, W;Steinmetzer, T;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity

Bento, D;Staats, HF;Gonalves, T;Borges, O;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Analysis of protective antigen peptide binding motifs using bacterial display technology

Sarkes, DA;Dorsey, BL;Stratis-Cullum, DN;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants

Lu, F;Mencia, A;Bi, L;Taylor, A;Yao, Y;HogenEsch, H;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures

Boyer, AE;Gallegos-Candela, M;Quinn, CP;Woolfitt, AR;Brumlow, JO;Isbell, K;Hoffmaster, AR;Lins, RC;Barr, JR;

Product: Anthrax Protective Antigen, Activated (PA 63) from B. anthracis

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis